Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2018 When Should Iatrogenic Polypharmacy Be Considered a Disease? Christine Wieseler, PhD When symptoms of polypharmacy are consistent with those of difficult-to-diagnose disorders, reliable determinations about which drugs are necessary is critical. AMA J Ethics. 2018;20(12):E1133-1138. doi: 10.1001/amajethics.2018.1133. Case and Commentary Jan 2020 How Should Clinicians Integrate Mental Health Into Epidemic Responses? Shantanu Srivatsa and Kearsley A. Stewart, PhD Culturally appropriate responsiveness to mental illnesses is critical to mitigating local persons’ distrust of international clinicians. AMA J Ethics. 2020;22(1):E10-15. doi: 10.1001/amajethics.2020.10. Case and Commentary Aug 2022 Underrecognition of Dysmenorrhea Is an Iatrogenic Harm Zainab Doleeb, MD, Liam G. McCoy, MD, MSc, Jazleen Dada, MBChB, and Catherine Allaire, MD Underrecognition and lack of awareness about how to help patients with painful menstruation constitute injustice and a health care harm. AMA J Ethics. 2022;24(8):E740-747. doi: 10.1001/amajethics.2022.740. Case and Commentary Nov 2005 Controlling Diabetes Robert P. Hoffman, MD Virtual Mentor. 2005;7(11):723-726. doi: 10.1001/virtualmentor.2005.7.11.ccas1-0511. Case and Commentary Apr 2024 How Should Regulators and Manufacturers Prevent Avoidable Deaths of Children From Contaminated Cough Syrup? Kavitha Nallathambi, MPH, MBA and Amy B. Cadwallader, PhD Quality control testing is ethically and clinically key to increasing transparency in excipient supply chains. AMA J Ethics. 2024;26(4):E289-294. doi: 10.1001/amajethics.2024.289.
Case and Commentary Dec 2018 When Should Iatrogenic Polypharmacy Be Considered a Disease? Christine Wieseler, PhD When symptoms of polypharmacy are consistent with those of difficult-to-diagnose disorders, reliable determinations about which drugs are necessary is critical. AMA J Ethics. 2018;20(12):E1133-1138. doi: 10.1001/amajethics.2018.1133.
Case and Commentary Jan 2020 How Should Clinicians Integrate Mental Health Into Epidemic Responses? Shantanu Srivatsa and Kearsley A. Stewart, PhD Culturally appropriate responsiveness to mental illnesses is critical to mitigating local persons’ distrust of international clinicians. AMA J Ethics. 2020;22(1):E10-15. doi: 10.1001/amajethics.2020.10.
Case and Commentary Aug 2022 Underrecognition of Dysmenorrhea Is an Iatrogenic Harm Zainab Doleeb, MD, Liam G. McCoy, MD, MSc, Jazleen Dada, MBChB, and Catherine Allaire, MD Underrecognition and lack of awareness about how to help patients with painful menstruation constitute injustice and a health care harm. AMA J Ethics. 2022;24(8):E740-747. doi: 10.1001/amajethics.2022.740.
Case and Commentary Nov 2005 Controlling Diabetes Robert P. Hoffman, MD Virtual Mentor. 2005;7(11):723-726. doi: 10.1001/virtualmentor.2005.7.11.ccas1-0511.
Case and Commentary Apr 2024 How Should Regulators and Manufacturers Prevent Avoidable Deaths of Children From Contaminated Cough Syrup? Kavitha Nallathambi, MPH, MBA and Amy B. Cadwallader, PhD Quality control testing is ethically and clinically key to increasing transparency in excipient supply chains. AMA J Ethics. 2024;26(4):E289-294. doi: 10.1001/amajethics.2024.289.